SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
BRADLEY PHARMACEUTICALS (BPRXA)
An SI Board Since March 1996
Posts SubjectMarks Bans
41 0 0
Emcee:  Brad Glassma Type:  Unmoderated
Introduction Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
16 Thanks Brad, have a good weekend. PLpaul lin-4/5/1996
15 BRADPHARM certainly warrants attention. I believe earnings will be out shortlyBrad Glassma-4/3/1996
14 Thanx Brad. Two more questions: What is their 4Q earning of 1995? I have alreadpaul lin-3/29/1996
13 The company took a charge in third quarter 1995 due to an incorrect amount of Brad Glassma-3/27/1996
12 Hi, Brad, do you know why it drops all the way from around 5 to 1.5? Appreciatpaul lin-3/26/1996
11 I see, it makes a lot more sense then.olduser-3/25/1996
10 The strategy employed by BRADLEY PHARMACEUTICALS is the identical one which MEBrad Glassma-3/25/1996
9 But if the products are little, and the big wants to sell to the small, there molduser-3/25/1996
8 It is not in their economies of scope or economies of scale. It 's not thBrad Glassma-3/25/1996
7 I don't get it, why can't a billion dollar company turn a 2 million dololduser-3/25/1996
6 No, it's just the simple fact that for MERCK, SANDOZ, AHP, or etc. it doesBrad Glassma-3/25/1996
5 I see, in the pharmaceuticals, would you say that the trend is to increase sharolduser-3/25/1996
4 I believe talks are going on all the time. The firm is looking for many differBrad Glassma-3/25/1996
3 Are they in talks for possible merger or takeover by the larger firms or have tolduser-3/24/1996
2 In the respiratory field, which comprises 60%-70% of the firm's revenue, DEBrad Glassma-3/24/1996
1 What specifically is their variety of products?olduser-3/23/1996
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News